Pure Global AI
Manufacturer profile

CHARLES RIVER LABORATORIES, INC.

BrazilUnited States2 ANVISA registrations1 unique technical categoryMar 12, 1998 – Mar 25, 2013
Verified
2
Total products
1
Technical names
Mar 1998
Earliest registration
Mar 2013
Latest registration
Regulatory footprint
Search CHARLES RIVER LABORATORIES, INC. across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this manufacturer
MATERIALS FOR ENDOTOXIN DETECTION
Limulus Amebocyte Lysate - Cartuchos PTS
Class II · Mar 25, 2013
MATERIALS FOR ENDOTOXIN DETECTION
LAL ENDOCHROME-K
Class II · Mar 12, 1998
Most popular products
Products with most registrations
MATERIALS FOR ENDOTOXIN DETECTION
2 registrations
Top registration holders
Companies holding product registrations for this manufacturer
ALKO DO BRASIL INDUSTRIA E COMERCIO LTDA
2 products
Top competitors
Companies with the most overlapping products (same technical names)
LONZA WALKERSVILLE, INC.
United States
1 registrations1 shared products
Shared products
MATERIALS FOR ENDOTOXIN DETECTION
CHARLES RIVER ENDOSAFE INC.
United States
1 registrations1 shared products
Shared products
MATERIALS FOR ENDOTOXIN DETECTION
About this profile

Explore comprehensive manufacturer profile for CHARLES RIVER LABORATORIES, INC. based in United States through Pure Global AI's free Brazil medical device database. This manufacturer has 2 products registered with ANVISA across 1 unique technical categories. Their regulatory history spans from Mar 12, 1998 to Mar 25, 2013.

This page provides detailed insights including 2 recent product registrations including MATERIALS FOR ENDOTOXIN DETECTION, 1 most popular products with MATERIALS FOR ENDOTOXIN DETECTION having 2 registrations, 1 registration holders including ALKO DO BRASIL INDUSTRIA E COMERCIO LTDA, and 2 key competitors with LONZA WALKERSVILLE, INC. sharing 1 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.